Abstract
The incidence of Merkel Cell Carcinoma (MCC) is increased in immunocompromised patients. We report the prognostic impact of a simple, easy to test laboratory value, absolute lymphocyte count (ALC), as a surrogate of immune status for patients treated for MCC at Fox Chase Cancer Center (FCCC) from 1992 to 2010.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
